Several of the current HTS approaches for CF drug discovery are based on a functional assay, whereby the fluorescence quenching of YFP-transfected cells due to iodide influx is used as a proxy for CFTR function under HT screens26, 30, including compound screens31. This evidence concerns the gene CFTR and cystic fibrosis.